Skip to content
Patients
HCPs
X-twitter Instagram Youtube Icon-mail Tiktok
Follow on X
Home
Daily Updates

Categories

Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium.

  • Post category:Hematologic Cancers
  • Reading time:2 mins read

This multicenter U.S. retrospective study evaluated 130 relapsed/refractory multiple myeloma patients treated with comme...

Continue ReadingReal-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium.

Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial.

  • Post category:Hematologic Cancers
  • Reading time:2 mins read

This publication reports stage 1 results of PRESERVE-003, a two‑stage phase 3 trial testing gotistobart (BNT316/ONC‑...

Continue ReadingGotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial.

Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemia.

  • Post category:Hematologic Cancers
  • Reading time:2 mins read

This study evaluated how specific genetic lesions add to MRD-based risk stratification in adult core-binding factor (CBF...

Continue ReadingGenetic alterations and measurable residual disease in core binding factor acute myeloid leukemia.

Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma.

  • Post category:Hematologic Cancers
  • Reading time:2 mins read

This publication reports an external control comparison of linvoseltamab, a BCMA×CD3 bispecific antibody, in heavily pr...

Continue ReadingLinvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma.

Comparable outcomes of HSCT up-front and after failure of IST in pediatric aplastic anemia in recent years.

  • Post category:Hematologic Cancers
  • Reading time:2 mins read

Study type - Retrospective analysis of 179 children with severe aplastic anemia undergoing allogeneic HSCT. Cohorts...

Continue ReadingComparable outcomes of HSCT up-front and after failure of IST in pediatric aplastic anemia in recent years.

Significant clinical impact of immunosuppressive therapy termination after allogeneic haematopoietic stem cell transplantation.

  • Post category:Hematologic Cancers
  • Reading time:1 min read

This retrospective registry study evaluated the impact of stopping systemic immunosuppression within 2 years after allog...

Continue ReadingSignificant clinical impact of immunosuppressive therapy termination after allogeneic haematopoietic stem cell transplantation.
  • © Together4Cancer. All rights reserved.
  • Privacy Policy
  • Terms of Use